Surgitech Innovation Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 15.35 Cr
as on 16-11-2024
- Revenue 63.81%
(FY 2023)
- Profit 103.03%
(FY 2023)
- Ebitda 74.28%
(FY 2023)
- Net Worth 65.55%
(FY 2023)
- Total Assets 50.52%
(FY 2023)
About Surgitech Innovation
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹15.35 Cr.
Rajesh Kalra, Anju Kalra, Ankit Kalra, and One other member serve as directors at the Company.
- CIN/LLPIN
U36998HR2018PTC073444
- Company No.
073444
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Apr 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Karnal, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Surgitech Innovation?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ankit Kalra  | Director | 06-Apr-2018 | Current |
| Rajesh Kalra | Director | 06-Apr-2018 | Current |
| Anju Kalra | Director | 06-Apr-2018 | Current |
| Akshay Kalra | Director | 09-Dec-2022 | Current |
Financial Performance of Surgitech Innovation.
Surgitech Innovation Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 63.81% increase. The company also saw a substantial improvement in profitability, with a 103.03% increase in profit. The company's net worth Soared by an impressive increase of 65.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Surgitech Innovation?
In 2022, Surgitech Innovation had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bioflex International Private LimitedActive 6 years 9 monthsRajesh Kalra, Anju Kalra and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 28 Oct 2024 | ₹3.58 M | Open |
Others Creation Date: 18 Jul 2023 | ₹6.50 Cr | Open |
Others Creation Date: 18 Jul 2023 | ₹2.00 Cr | Open |
How Many Employees Work at Surgitech Innovation?
Surgitech Innovation has a workforce of 157 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Surgitech Innovation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Surgitech Innovation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
